ArticleLeukemia2017
Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations.
M Marchetti et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this paperpooled ittrialcites it